HMI-102-102: An Open-Label, Long-Term Follow-Up Study of Safety and Efficacy in PKU Subjects with PAH Deficiency Previously Administered HMI-102

Project: Research project

Project Details

StatusActive
Effective start/end date6/11/20 → 8/31/50

Funding

  • Homology Medicines, Inc.